Leveraging Patient Reported Outcomes Measurement via the Electronic Health Record to Connect Patients with Cancer to Smoking Cessation Treatment.
cancer
electronic health record
oncology
patient reported outcomes
quality improvement
smoking cessation
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
13 07 2020
13 07 2020
Historique:
received:
19
05
2020
revised:
05
07
2020
accepted:
08
07
2020
entrez:
17
7
2020
pubmed:
17
7
2020
medline:
1
12
2020
Statut:
epublish
Résumé
Tobacco use negatively impacts cancer treatment outcomes, yet too few providers actively support their patients in quitting. Barriers to consistently addressing tobacco use and referring to treatment include time constraints and lack of knowledge surrounding treatment options. Patient Reported Outcomes (PRO) measurement is best practice in cancer care and has potential to help address these barriers to tobacco cessation treatment. This descriptive program evaluation study reports preliminary results following implementation of a novel automated PRO tobacco use screener and referral system via the electronic health record (EHR) patient portal (MyChart) that was developed and implemented as a part of a population-based tobacco treatment program at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. Between 25 June 2019 and 6 April 2020, 4589 unique patients completed the screener and 164 (3.6%) unique patients screened positive for recent (past month) cigarette smoking. All patients who screened positive were automatically referred to a smoking cessation treatment program integrated within the Lurie Cancer Center, and 71 (49.7%) patients engaged in treatment, as defined by completing at least one behavioral counseling session. Preliminary results indicate that the PRO/MyChart system may improve smoker identification and increase offering of treatment and, despite the "cold call" following a positive screen, may result in a treatment engagement rate that is higher than rates of treatment engagement previously documented in oncology settings. Longer term evaluation with formal statistical testing is needed before drawing conclusions regarding effectiveness, but PRO measurement via the EHR patient portal may serve a potentially important role in a multi-component approach to reaching and engaging cancer patients in comprehensive tobacco cessation treatment.
Identifiants
pubmed: 32668758
pii: ijerph17145034
doi: 10.3390/ijerph17145034
pmc: PMC7399884
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NCI NIH HHS
ID : 3P30CA060553-24S1.
Pays : United States
Références
Cancer. 2019 Nov 15;125(22):4059-4068
pubmed: 31373682
Cochrane Database Syst Rev. 2008 Apr 16;(2):CD000165
pubmed: 18425860
J Community Support Oncol. 2015 Dec;13(12):423-8
pubmed: 26863872
Palliat Support Care. 2014 Feb;12(1):69-73
pubmed: 24128592
Support Care Cancer. 2012 Jan;20(1):175-83
pubmed: 21331484
J Oncol Pract. 2013 Sep;9(5):258-62
pubmed: 23943904
J Bras Pneumol. 2015 Mar-Apr;41(2):124-32
pubmed: 25972966
Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):414-9
pubmed: 20399030
Transl Behav Med. 2019 Jul 17;:
pubmed: 31313808
Community Oncol. 2012 Nov 1;9(11):344-352
pubmed: 23175636
JAMIA Open. 2019 Apr;2(1):73-80
pubmed: 30976756
Asia Pac J Clin Oncol. 2018 Dec;14(6):431-438
pubmed: 29706029
J Natl Compr Canc Netw. 2016 Nov;14(11):1430-1468
pubmed: 27799513
Cancer Prev Res (Phila). 2019 Nov;12(11):735-740
pubmed: 31481540
J Natl Compr Canc Netw. 2016 Nov;14(11):1469-1477
pubmed: 27799514
Oncologist. 2019 Feb;24(2):229-238
pubmed: 30446582
Cancer. 2016 Jun 1;122(11):1728-34
pubmed: 27019325
Cancer Causes Control. 2013 Jun;24(6):1223-30
pubmed: 23553611
J Clin Oncol. 2007 Oct 10;25(29):4526-7
pubmed: 17846452
Lung Cancer. 2007 Feb;55(2):215-24
pubmed: 17084483
Support Care Cancer. 2017 Jan;25(1):103-110
pubmed: 27565789
J Public Health Manag Pract. 2018 Sep/Oct;24(5):E12-E19
pubmed: 29278577
Clin Adv Hematol Oncol. 2016 Dec;14(12):999-1009
pubmed: 28212362
Int J Environ Res Public Health. 2020 Jun 06;17(11):
pubmed: 32517176
Int J Environ Res Public Health. 2020 Mar 22;17(6):
pubmed: 32235713
BMJ. 2004 Jun 19;328(7454):1470
pubmed: 15194599
Cancer Epidemiol Biomarkers Prev. 2014 Jan;23(1):3-9
pubmed: 24420982
Int J Environ Res Public Health. 2020 Mar 24;17(6):
pubmed: 32213994
J Adv Pract Oncol. 2019 Mar;10(2):175-179
pubmed: 31538028
Health Educ Behav. 2013 Jun;40(3):266-73
pubmed: 22984217
Prev Med. 2004 Sep;39(3):449-57
pubmed: 15313083
Front Public Health. 2020 Jun 12;8:221
pubmed: 32596200
Int J Environ Res Public Health. 2020 May 31;17(11):
pubmed: 32486463
Curr Oncol. 2019 Dec;26(6):361-368
pubmed: 31896934
Eur J Gen Pract. 2015 Jun;21(2):111-7
pubmed: 25649048
J Natl Compr Canc Netw. 2016 Oct;14(10):1259-1266
pubmed: 27697980
Clin J Oncol Nurs. 2007 Dec;11(6):817-21
pubmed: 18063540
J Thorac Oncol. 2015 Nov;10(11):1532-7
pubmed: 26317914
Drug Alcohol Depend. 2013 Oct 1;132(3):479-85
pubmed: 23570817
Cochrane Database Syst Rev. 2016 Mar 24;3:CD008286
pubmed: 27009521
Qual Life Res. 2020 Feb;29(2):347-355
pubmed: 31606809
J Natl Compr Canc Netw. 2019 Jun 1;17(6):638-643
pubmed: 31200354
Oncology. 2018;95(3):129-137
pubmed: 29920482
Ann Surg Oncol. 2012 May;19(5):1430-8
pubmed: 22065194
Addiction. 2015 Mar;110(3):381-6
pubmed: 25323093
Health Psychol. 2014 May;33(5):490-9
pubmed: 24447188